129
Participants
Start Date
August 2, 2013
Primary Completion Date
March 26, 2018
Study Completion Date
March 26, 2018
FAI insert
Sham injection
Retina Consultants, Slingerlands
Duke University Eye Center, Durham
Charleston Neuroscience Institute, Ladson
Ophthalmology & Visual Sciences, Lexington
Cleveland Clinic, Cleveland
Northwestern University, Chicago
University of Nebraska Medical Center, Omaha
Texas Retina Associates, Arlington
Retina Consultants of Houston, Houston
Foresight Studies, LLC, San Antonio
Retina Consultants of Southern Colorado, Colorado Springs
Retina Vitreaous Associates, Beverly Hills
Retina Macula Institute, Torrance
Retinal Consultants Medical Group, Inc, Sacramento
OHSU Casey Eye Institute, Portland
Ocular Immunology and Uveitis Foundation, Cambridge
Augenarzte am St. Franziskus Hospital, Münster
Universitatsklinikum Tubingen, Tübingen
Bajcsy-Zsilinszky Kórház és Rendelőintézet, Budapest
L. V. Prasad Eye Institute - Hospital, Hyderabad
L.V. Prasad Eye Institute, Pātia
C.H Nagri Municipal Eye Hospital, Ahmedabad
Seth G.S. Medical College & KEM Hospital, Pārel
PBMA'S H.V. Desai Eye Hospital, Hadapsar
King George's Medical University, Lucknow
Hadassah University Hospital Ein Kerem, Jerusalem
Rabin Medical Center, Petah Tikva
Sheba Medical Center, Qiryat Ono
Royal Hospitals Trust, Belfast
Birmingham and Midland Eye Centre, Birmingham
Bradford Royal Infirmary, Bradford
Gloucestershire Royal Hospital, Gloucester
Moorfields Eye Hospital, London
St Thomas Hospital, London
Lead Sponsor
EyePoint Pharmaceuticals, Inc.
INDUSTRY